Latest newsView all news
Expansion of the Pathology Range with RevMAb antibodies
January 16, 2015 - RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma.
Exclusive products from ESI BIO, now available
January 15, 2015 - Sanbio signed an exclusive contract with ESI BIO, division of BioTime Inc. The breakthrough stem cell technologies, light the path from research to clinic in order to help our customers with their goal of treating disease.
- Meet our colleagues this Friday at the BeSHG meeting in Charleroi, Belgium. "Behaviour: is it genetically... http://t.co/Vk7JFnT99r March 02, 2015 - Sanbio B.V.
- Watch now: The foundation for an integrated NGS workflow solution http://t.co/H49jysqaYy February 26, 2015 - Sanbio B.V.
- Lees onze nieuwe blog; Herprogrammering van stamcellen http://t.co/sRrR5JDcAr February 24, 2015 - Sanbio B.V.